Jane Pritchard

2.6k total citations
34 papers, 1.2k citations indexed

About

Jane Pritchard is a scholar working on Neurology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Jane Pritchard has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Immunology. Recurrent topics in Jane Pritchard's work include Peripheral Neuropathies and Disorders (18 papers), Hereditary Neurological Disorders (12 papers) and Nerve injury and regeneration (7 papers). Jane Pritchard is often cited by papers focused on Peripheral Neuropathies and Disorders (18 papers), Hereditary Neurological Disorders (12 papers) and Nerve injury and regeneration (7 papers). Jane Pritchard collaborates with scholars based in United Kingdom, United States and Netherlands. Jane Pritchard's co-authors include Terry J. Smith, William W. Cruikshank, Richard AC Hughes, Rui Han, Claire White, Lynne Turner‐Stokes, Man Mohan Mehndiratta, Anna Makowska, Robert D. M. Hadden and Norman A. Gregson and has published in prestigious journals such as The Lancet, The Journal of Immunology and Neurology.

In The Last Decade

Jane Pritchard

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Pritchard United Kingdom 18 490 422 287 278 130 34 1.2k
Txomin Arbizu Spain 16 370 0.8× 255 0.6× 197 0.7× 48 0.2× 9 0.1× 29 913
Ruth Prieto Spain 24 282 0.6× 97 0.2× 85 0.3× 807 2.9× 14 0.1× 98 1.6k
Gülay Alper United States 19 729 1.5× 677 1.6× 202 0.7× 34 0.1× 128 1.0× 33 1.4k
Andrew Chancellor United Kingdom 22 909 1.9× 137 0.3× 383 1.3× 20 0.1× 24 0.2× 49 2.2k
John A. Simpson United Kingdom 11 689 1.4× 37 0.1× 46 0.2× 113 0.4× 74 0.6× 19 1.0k
Irene Scheimberg United Kingdom 18 120 0.2× 75 0.2× 25 0.1× 185 0.7× 227 1.7× 46 1.4k
Neil Friedman United States 20 294 0.6× 53 0.1× 44 0.2× 27 0.1× 25 0.2× 59 1.2k
S. Variend United Kingdom 20 238 0.5× 102 0.2× 33 0.1× 47 0.2× 9 0.1× 49 1.2k
Tetsuya Akaishi Japan 21 1.1k 2.2× 1.1k 2.5× 120 0.4× 14 0.1× 119 0.9× 136 1.8k
Petri Kulmala Finland 30 223 0.5× 104 0.2× 118 0.4× 1.8k 6.3× 16 0.1× 82 4.0k

Countries citing papers authored by Jane Pritchard

Since Specialization
Citations

This map shows the geographic impact of Jane Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Pritchard more than expected).

Fields of papers citing papers by Jane Pritchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Pritchard. The network helps show where Jane Pritchard may publish in the future.

Co-authorship network of co-authors of Jane Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Pritchard. A scholar is included among the top collaborators of Jane Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Pritchard. Jane Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burke, Georgina, Maria Elena Farrugia, Pablo Garcia-Reitboeck, et al.. (2025). Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience. Journal of Neurology Neurosurgery & Psychiatry. 96(4). 322–328. 4 indexed citations
2.
Muraro, Paolo A., et al.. (2020). The Use of Rituximab in Neurological Diseases; Real World Data from a Neuroscience Centre (2575). Neurology. 94(15_supplement). 1 indexed citations
3.
Pritchard, Jane, Richard AC Hughes, Robert D. M. Hadden, & Ruth Brassington. (2016). Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. 1. CD008630–CD008630. 41 indexed citations
4.
Hughes, Richard AC, Jane Pritchard, & Robert D. M. Hadden. (2013). Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. CD008630–CD008630. 15 indexed citations
5.
Pritchard, Jane. (2008). What's new in Guillain-Barré syndrome?. Postgraduate Medical Journal. 84(996). 532–538. 8 indexed citations
6.
Gregson, Norman A., Gaiping Zhang, Jane Pritchard, et al.. (2007). Characterization of a monoclonal antibody specific for human peripheral myelin protein 22 and its use in immunohistochemical studies of the fetal and adult nervous system. Journal of the Peripheral Nervous System. 12(1). 2–10. 2 indexed citations
7.
Makowska, Anna, Jane Pritchard, Lara Sanvito, et al.. (2007). Immune responses to myelin proteins in Guillain-Barre syndrome. Journal of Neurology Neurosurgery & Psychiatry. 79(6). 664–671. 45 indexed citations
8.
Pritchard, Jane, Anna Makowska, Norman A. Gregson, Adrian Hayday, & Richard AC Hughes. (2007). Reduced circulating CD4+CD25+ cell populations in Guillain–Barré syndrome. Journal of Neuroimmunology. 183(1-2). 232–238. 27 indexed citations
9.
Allen, David C., I. A. Gray, Norman A. Gregson, et al.. (2005). Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System. 10(2). 174–180. 63 indexed citations
10.
McIlveen, Myvanwy, et al.. (2005). Modern embryo transfer catheters and pregnancy outcome: a prospective randomized trial. Fertility and Sterility. 84(4). 996–1000. 14 indexed citations
11.
Sorge, Nina M. van, W. Ludo van der Pol, Marc Jansen, et al.. (2005). Severity of Guillain–Barré syndrome is associated with Fcγ Receptor III polymorphisms. Journal of Neuroimmunology. 162(1-2). 157–164. 44 indexed citations
12.
Hughes, Richard AC, Jane Pritchard, Zhannat Idrissova, et al.. (2004). A pilot randomised, double blind, placebo controlled exploratory safety study of the use of interferon-beta 1a in the treatment of Guillain-Barre syndrome. Journal of Neurology Neurosurgery & Psychiatry. 75(5). 3 indexed citations
13.
Pritchard, Jane, et al.. (2004). Guillain-Barré syndrome seen in users of isotretinoin. BMJ. 328(7455). 1537–1537. 21 indexed citations
14.
Pritchard, Jane. (2003). Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome. Journal of Neurology Neurosurgery & Psychiatry. 74(7). 971–973. 10 indexed citations
15.
16.
Pritchard, Jane, et al.. (2002). Igs from Patients with Graves’ Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts. The Journal of Immunology. 168(2). 942–950. 136 indexed citations
17.
Pritchard, Jane. (2000). Novel therapeutic approaches to Guillain-Barré syndrome. Expert Opinion on Investigational Drugs. 9(10). 2307–2318. 9 indexed citations
18.
Evans, John, Diana M. Gibb, F John Holland, et al.. (1997). Malignancies in UK children with HIV infection acquired from mother to child transmission. Archives of Disease in Childhood. 76(4). 330–333. 47 indexed citations
19.
Forster, G E, Jane Pritchard, P E Munday, & David Goldmeier. (1986). Incidence of sexually transmitted diseases in rape victims during 1984.. Sexually Transmitted Infections. 62(4). 267–269. 14 indexed citations
20.
Fisher‐Hoch, Susan P., et al.. (1981). INVESTIGATION AND CONTROL OF AN OUTBREAK OF LEGIONNAIRES' DISEASE IN A DISTRICT GENERAL HOSPITAL. The Lancet. 317(8226). 932–936. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Txomin Arbizu Breakdown of academic impact, for papers by Ruth Prieto Breakdown of academic impact, for papers by Gülay Alper Breakdown of academic impact, for papers by Andrew Chancellor Breakdown of academic impact, for papers by John A. Simpson Breakdown of academic impact, for papers by Irene Scheimberg Breakdown of academic impact, for papers by Neil Friedman Breakdown of academic impact, for papers by S. Variend Breakdown of academic impact, for papers by Tetsuya Akaishi Breakdown of academic impact, for papers by Petri Kulmala
Rankless by CCL
2026